Literature DB >> 6600770

A quantitative analysis of cell surface glycosphingolipid with a fluorescence activated cell sorter.

M Iwamori, M Mogi, Y Hirano, M Nishio, H Nakauchi, K Okumura, Y Nagai.   

Abstract

The fluorescence activated cell sorter (FACS) was used with an indirect membrane immunofluorescence technique to detect antibody against the Forssman antigen, a glycosphingolipid. Sheep erythrocytes, which contain Forssman antigen as a major membrane glycosphingolipid, were used as the target antigen. Detection of the anti-Forssman antibody on the sheep erythrocytes was done with specific fluorescein-conjugated second antibody and analyzed on a FACS. Compared to other available methods, analysis with the FACS was simple, sensitive, reproducible and quantitative. More than 250 pg of antibody could be detected. In addition, as little as 1 ng of Forssman antigen could be estimated by a binding inhibition experiment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600770     DOI: 10.1016/0022-1759(83)90098-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Concanavalin A-stimulated expression of gangliosides with GalNAc beta 1-4(NeuAc alpha 2-3)Gal beta structure in murine thymocytes.

Authors:  K Horikawa; M Yamasaki; M Iwamori; H Nakakuma; K Takatsuki; Y Nagai
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

2.  Contribution of glycolipids to species-specific antigens on erythrocytes of several animal species as to recognition of antigens with rabbit anti-glycolipids and anti-erythrocyte antisera.

Authors:  Masao Iwamori; Makoto Murata; Mariko Toyoda; Yuriko Iwamori
Journal:  Glycoconj J       Date:  2008-10-16       Impact factor: 2.916

3.  Cryoprecipitation of an anti-Pr2 monoclonal IgM cold agglutinin in the presence of GM3 ganglioside.

Authors:  P Yeni; M L Harpin; B Habibi; A Billecocq; M J Morelec; J P Clauvel; F Danon; N Baumann; J C Brouet
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.